67Cu-SAR-bisRGD (Clarity Pharmaceuticals)

N/A

Report date: 2025/10/28 16:07:09

Base Information

Drug Name67Cu-SAR-bisRGD (Clarity Pharmaceuticals)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Copper > 67CuRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionIntegrin alpha-V/beta-3 binders

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesClarity Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesClarity Pharmaceuticals Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A